First human trial tests new mental health Drug's safety
NCT ID NCT06702332
Summary
This was the first study in humans to test the safety of a new oral drug called MSD-001, which is being developed for mental health conditions. It involved 47 healthy adults who received a single dose to see how their bodies reacted and processed the drug. The main goal was to check for side effects and understand how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENTAL HEALTH DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Human Drug Research
Leiden, South Holland, Netherlands
Conditions
Explore the condition pages connected to this study.